Status:
RECRUITING
Atrial Fibrillation Patients Treated With Catheter Ablation
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Atrial Fibrillation
Atrial Fibrillation Recurrent
Eligibility:
All Genders
18-80 years
Brief Summary
This is a single-center prospective observational cohort study of atrial fibrillation patients treated with radiofrequency ablation.
Detailed Description
The effect of radiofrequency therapy on the life quality and atrial function of atrial fibrillation patients will be assessed, through the multidimensional analysis of baseline clinical data, serologi...
Eligibility Criteria
Inclusion
- Non-valvular atrial fibrillation, including paroxysmal atrial fibrillation and persistent atrial fibrillation
- 18-80 years old
- The anteroposterior diameter of the left atrium is less than 50mm via TTE
- Patient meets the intervention criteria for bilateral pulmonary vein isolation after evaluation by electrophysiological specialists
- Patient consents to ablation treatment
Exclusion
- Intra-atrial thrombus detected by TEE
- Hyperthyroidism
- Previous radiofrequency ablation for atrial fibrillation
Key Trial Info
Start Date :
September 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05266144
Start Date
September 4 2020
End Date
December 31 2025
Last Update
June 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100005